Blood Gas Analyzer Market

Blood Gas Analyzer Market Overview

The global Blood Gas Analyzer Market size was valued at USD 725.0 million in 2024 and is predicted to reach USD 963.5 million by 2030 with a CAGR of 4.9% from 2025-2030. 

The market grows due to the rising prevalence of chronic diseases, growing aging population and rise in number of new-born premature infants that requires regular assessment to monitor and manage health conditions. However, the high acquisition cost of these analyzers slows down the overall growth of the market. On the contrary, advancement in technologies including intelligent automation and ion-selective electrode is anticipated to create future opportunity for the growth of the market. The major players operating in the market are as Abbott Laboratories and Medica Corporation among others are adopting various business strategies including product launches to enhance their market expansion and broaden their product offering. As the technologies expand, the market is set for further revolution as intelligent automation in these analyzers will enhances the efficiency of blood gas testing by reducing human error and improve the speed of testing. 

Rising Chronic Diseases Worldwide Fuels the Growth of the Market

Increasing numbers of chronic illnesses are driving the demand for blood gas analyser, with doctors and other health professionals looking for efficient diagnostic devices to enhance patient care. According to reports published by United Nations, 2024, cancer incidence globally will rise by 77% to 2050, while more affluent nations are projected to develop an additional 4.8 million new cancer cases. This rise in chronic illnesses is increasing blood gas analysers, to enable early and accurate monitoring of patients.

Aging Population Driving Demand for Blood Gas Analysers

Increased aging population is fuelling demand for blood gas analyzers industry as the older population is in a higher proportion afflicted with respiratory, cardiovascular, and metabolic conditions and hence require non-stop monitoring. As per reports of World Health Organization, 2024, the overall proportion of the aging population across the globe will increase from 10% in 2021 to 17% in 2050. This massive increase in the aging population is driving the need for advanced diagnostic machines such as electrolyte analyzers to meet elderly healthcare needs. 

Rising Neonatal Care Needs Driving the Blood Gas Analyzer Market 

The increasing focus on neonatal care is highly driving demand for blood gas analysers since infants, especially premature and critically ill infants need oxygen and acid-base balance checked constantly for survival. According to reports published by UNICEF 2024, approximately 2.3 million new-borns died in the first month of 2022, an average of about 6,300 deaths per day. The startling number requires advanced neonatal care technologies, and blood gas analysers play a crucial role in early diagnosis and treatment.

High Cost of these Analysers Limiting Market Trends

The high price of blood gas analysers, plus the cost of maintenance and calibration, is one of the most significant obstacles to mass adoption. Smaller medical facilities and clinics are not readily able to provide such sophisticated diagnostic equipment, inhibiting market expansion and availability in resource-poor environments.

Incorporation of Artificial Intelligence into Blood Gas Analysers Creates Market Growth Opportunity

Incorporation of artificial intelligence (AI) into blood gas analysers is one of the key growth opportunities that enable quicker, more accurate diagnostics using less human inputs. AI based systems can enhance predictive analysis more effectively, automate reporting, and enhance workflow productivity and are thus of invaluable assistance in critical care and emergency settings. 

Market Segmentations and Scope of the Study 

The blood gas analyzer market report is segmented by product type, modality, end-user, and region. On the basis of product type, the market is classified into i-Stat, ePOC, GEM premier, ABL Flex, cobas, RAPID series and others. GEM premier is further segmented into GEM 3000, GEM 3500, GEM 4000 and others. Furthermore, ABL Flex is bifurcated into, ABL800, ABL80, ABL90 and others. Cobas is further divided into, cobas b 221, cobas b 121, cobas b 123 and others. On the basis of modality, the market is bifurcated into portable and bench-top. On the basis of end-user, the market is divided into hospital, diagnostics centres, clinics, ambulatory surgical centres, educational institutes and others. Regional breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America region dominants the blood gas analyser market share and is expected to continue to its dominance during the forecast period. The growing investment by the U.S. government in healthcare is fueling demand for advanced diagnostic equipment including blood gas analysers. The latest report published by World Economic Forum stated that venture capital spending on healthcare is anticipated to reach USD 11 billion in 2024, adding to the country's USD 4.5 trillion healthcare sector. The investment is helping hospitals deploy better technology, improving patient care, and promoting more use of blood gas analysers. 

Additionally, increasing base of cancer patients in this region is propelling the market for blood gas analysers, that play an important part in monitoring critical care patients. As per the latest report published by Government of Canada, approximately 1 in 4 Canadians are expected to die from cancer, with a slightly higher probability for males (24%) compared to females (21%) in 2023. As additional cases of cancer continue to surface, cancer diagnostic equipment including blood gas analysers that are accurate and efficient play a more significant role in the Canadian healthcare system. 

On the other hand, Asia-pacific region shows a steady rise in blood gas analyzer market demand during the forecast period. This is attributed to the growing aging population in the region that is driving the need for integrated blood gas analyzers as elderly individuals are susceptible to chronic diseases that require regular monitoring. As per UNFPA reports, 2023, India's population of elderly persons will grow from 153 million in 2023 to 347 million by 2050 marking a growth of around 126% within 27 years. With more and more seniors needing advanced healthcare, the need for blood gas analyzers is projected grow. 

Moreover, the increasing rate of newborns in the region is pushing the Chinese market for blood gas analyzers due to these machines playing an imperative role within the neonatal sector for monitoring the level of oxygen, identification of respiratory distress, and speedy medical treatment. For example, in January 2025, the National Bureau of Statistics (NBS) announced that China had 9.54 million children born in 2024, 520,000 more than in 2023. While increased numbers of births multiplied demand for blood gas analyzers are being utilized ever more by Chinese hospitals and neonatal facilities to enhance baby health care results, spurring market growth. 

Competitive Landscape

Various players operating in the blood gas analyzer industry such Abbott Laboratories, Medica Corporation, Radiometer Medical ApS, Siemens Healthineers AG, Nova Biomedical, Erba Mannheim, Techno MedicaCo., Ltd., Horiba Medical, EDAN Instruments, Inc., OPTI Medical Systems, HDC India, Roche Diagnostics, Analytical Technologies Ltd., Diamond Diagnostics, Bioevopeak Co., Ltd. and others. These market players are adopting strategy including product launches to remain dominant in the market.

For example, in May 2024, Nova Biomedical gained the approval of the U.S. Food and Drug Administration (FDA) for Start Profile Prime Plus analyzer for a novel micro capillary sample mode for performing important blood tests with only 90 microliters of capillary blood. The technology includes an unprecedented drop in blood volume needs, enhancing patient safety and reducing the chance of anaemia among sick patients.

Key Benefits

• The report provides quantitative analysis and estimations of the blood gas analyzer market from 2025 to 2030, which assists in identifying the prevailing industry opportunities.

• The study comprises a deep-dive analysis of the current and future blood gas analyzer market  trends to depict prevalent investment pockets in the industry.

• Information related to key drivers, restraints, and opportunities and their impact on the blood gas analyzer market trend is provided in the report. 

• Competitive analysis of the key players, along with their market share is provided in the report.

• SWOT analysis and Porters Five Forces model is elaborated on the study.

• Value chain analysis in the market study provides a clear picture of roles of stakeholders.

Blood Gas Analyzer Market Key Segments

By Product Type

• i-Stat

• ePOC

• GEM Premier

  • GEM 3000

  • GEM 3500

  • GEM 4000

• ABL Flex

  • ABL800

  • ABL80

  • ABL90

• Cobas

  • Cobas b 221

  • Cobas b 121

  • Cobas b 123

• RAPID Series

• Others 

By Modality

• Portable

• Bench-top

By End-User

• Hospital

• Diagnostics Centres

• Clinics

•  Ambulatory Surgical Centres

• Educational Institutes

• Others

By Region

• North America

  • The U.S.

  • Canada

  • Mexico

• Europe

  • The UK

  • Germany

  • France        

  • Italy        

  • Spain        

  • Denmark        

  • Netherlands        

  • Finland        

  • Sweden        

  • Norway        

  • Russia

  • Rest of Europe

• Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Singapore

  • Taiwan

  • Thailand

  • Rest of Asia-Pacific 

• RoW

  • Latin America

  • Middle East 

  • Africa

Key Players

• Abbott Laboratories

• Medica Corporation

• Radiometer Medical ApS

• Siemens Healthineers AG

• Nova Biomedical

• Erba Mannheim

• Techno MedicaCo., Ltd.

• Horiba Medical

• EDAN Instruments, Inc.

• OPTI Medical Systems

• HDC India

• Roche Diagnostics

• Analytical Technologies Ltd

• Diamond Diagnostics

• Bioevopeak Co., Ltd.

REPORT SCOPE AND SEGMENTATION

Parameters	Details
Market Size in 2024	USD 725.0 million
Revenue Forecast in 2030	USD 963.5 million
Growth Rate	CAGR of 4.9% from 2025 to 2030
Analysis Period	2024–2030
Base Year Considered	2024
Forecast Period	2025–2030
Market Size Estimation	Million (USD)
Growth Factors	The increasing chronic diseases drives the growth of the market. The rising government investment in healthcare boosts the market growth. The expanding geriatric population further fuels the market growth.
Countries Covered	28
Companies Profiled	15
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent to up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.